Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µÎºÎ¿Ü»ó ȯÀÚ¿¡¼­ ValproateÀÇ ´ë»çÀÇ º¯È­ Metabolism of Valproate in Traumatic Brain Injury Patients

´ëÇÑ°£ÁúÇÐȸÁö 2003³â 7±Ç 1È£ p.33 ~ 36
±è¿øÁÖ, ÀÌÁø±¸, ¿À½ÂÇå, ±èÇö¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿øÁÖ ( Kim Won-Joo ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç

ÀÌÁø±¸ ( Lee Jin-Goo ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µµ¿¼¼ºê¶õ½ºº´¿ø ½Å°æ°úÇб³½Ç
¿À½ÂÇå ( Oh Seung-Hun ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÇö¼÷ ( Kim Hyun-Sook ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µµ¿¼¼ºê¶õ½ºº´¿ø ½Å°æ°úÇб³½Ç

Abstract


Purpose£ºTraumatic brain injuries induce plasma clearance of several compounds. Phenytoin is usually used for the prevention of posttraumatic seizure, and it is known that its clearance is increased in traumatic brain injury patients. Valproate is another important anti-epileptic drug for the prevention of posttraumatic seizure. We evalua-ted the metabolism of valproate in acute traumatic brain injury patie-nts.

Methods£ºFourteen traumatic brain injury patients were selected. They were given a loading dosage (15-20 mg/kg), and maintained with valproate. Trough serum valproate level was obtained during 7-20 days after an acute injury.

Results£ºThe total clearance level of valproate was higher in ac-ute traumatic brain injury patients than patients with chronic valproate use (7.70¡¾1.36 ml/kg/hr vs. 9.05¡¾1.91 ml/kg/hr, p<0.05).

Conclusions£ºAcute traumatic brain injury results in the induction of valproate metabolism during 7-20 acute days, and it is related to the enhancement of multiple metabolic pathways.

Å°¿öµå

Valproate;Metabolism;Brain injury;Drug cl-earance

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS